Receive the latest alerts via email

New Valuation: Vertex Pharmaceuticals Inc (VRTX)

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) 
(fair value)

Website https://www.vrtx.com
Sector Health Care
Industry Biotechnology
Fiscal Year End December
Market Cap $76B
Beta 0.46
Dividends per share $0.00
Current Price $292.04
Autochartist™ Valuation $293.00
Conclusion
(fair value)

Download PDF Report

Total
0
Shares
Previous Post

New Valuation: Marriott International Inc (MAR)

Next Post

New Valuation: Charter Communications Inc (CHTR)

Related Posts